CFO Edward J Dulac III sold $959K of Fate Therapeutics, Inc.

Sold$958,620

$60.00Price

15,977Shares

−13%Stake

What FATE did after the filing

Prices for FATE after this filing aren't in yet.

Traded Mon, Dec 20. Filed Tue, Dec 21, 11:08 AM ET, during the session. Not investment advice.